incidence of infertility in FGTB patients is rare up to date, the data is supposed to be high. 4 Female genital tuberculosis is usually symptom-less, nonspecific, mild clinical pictures and difficult for the differential diagnosis from other diseases such as cancer. MTB infection usually causes irreversible damage to the fallopian tube, endometrial, ovary and other genital organs with potential consequences of causing infertility and making it untreatable both by medical and surgical methods. 5 Thus, early diagnosis for FGTB is of paramount importance.
However, nonspecific manifestations and the lack of easy access to gold-standard diagnostic test render a diagnostic difficult for .5% in those with no clinical ground for suspicion. 6 Also, biopsy is commonly accepted in clinical FGTB diagnosis. However, sampled sites may not represent the infected area and the infected site can be simply missed due to sparse number of paucibacillary nature of MTB, particularly the poor compliance from patients.
Mondal et al 7 reported that caseation and acid-fast bacilli could be detected in only 13.23% and 5.88% specimens in histopathological examination. And positive X-ray, hysterosalpingography (HSG) and ultrasonographic examination may specify the need for further investigations. 8 In summary, main limitations to these methods for TB diagnosis are poor sensitivity and specificity. Therefore, improved diagnostics to identify presumptive FGTB cases early are accordingly in urgent need, which may facilitate prompt initiation of specific anti-tuberculosis therapy to control further damage to genital organs.
Interferon gamma release assays (IGRAs) have been developed for the rapid diagnosis of TB and screening for latent tuberculosis infection (LTBI), and widely used in TB diagnosis, especially the T-SPOT.TB is the one of most widely used IGRAs. [9] [10] [11] This assay allows enumeration of the number of responsive effector T-cells stimulated by M. tuberculosis specific antigens early secreted antigen target-6 (ESAT-6) and culture filtrate protein 10 (CFP-10), encoded in the genomic region of difference (RD) of MTB which are absent in most non tuberculosis mycobacterium, including the widely used TB vaccine bacillus Calmette-Guerin (BCG) in China. 12, 13 Previously meta-analysis demonstrated that the sensitivity and specificity of T-SPOT.TB were 90% for extra pulmonary tuberculosis. 10 Whereas, statistics of T-SPOT.TB on the diagnostic performance for FGTB is still limited.
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In this manuscript, a retrospective study was conducted with microbiologically/histopathologically and clinically confirmed FGTB patients to evaluate the diagnostic performance of T-SPOT.TB in FGTB diagnosis. The T-SPOT.TB result was considered as positive if spots for ESAT-6 or CFP-10 ≥ 6 SFCs/2.5 × 10 5 mononuclear cells, or had twice the number of spots than the negative control well. In addition, the background number of spots in the negative control well should be <10 SFCs. Otherwise, the result was considered as negative or invalid.
| MATERIAL S AND ME THODS

| Patients
| Other diagnostic tests
Specimens for microbiological/histopathological examination were processed according to the methods as Rozati et al 15 described.
Mycobacterial sears, culture, PCR and histopathological test were performed as Jia et al 7 described in previous study.
| Statistics analysis
Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated to evaluate diagnostic performance for T-SPOT.TB. 
| RE SULTS
| Patient characteristics
Among the 103 patients which were confirmed as FGTB, 52 were microbiologically/histopathologically confirmed (6 culture confirmed, 33 histopathologically confirmed and 13 were both confirmed microbiologically and histopathologically), the remaining 51 which showed no definitive evidence during diagnostic procedure (35 showed caseation, granuloma/tubercles and/or beaded/thickened tubes in laparoscopic imaging, the others only showed clinical symptoms such as abdominal distention/pain, dysmenorrheal, and menstrual irregularity etc.) were finally clinically confirmed as they were successfully responsive to anti-tuberculosis treatment. Furthermore, in FGTB group, there were 49 (47.57%) infertile females, significant higher than control group 5 (4.55%) (P < 0.01). This finding further confirmed that FGTB is one of the main causes of infertility. In the control group, 41 were pelvic inflammatory, 37 were cervical erosion, 6 were vaginitis, and the remaining 26 were finally diagnosed as other gynecological diseases (Table 1) .
Anatomical sites of FGTB were also investigated in this study.
Among the FGTB patients, endometrium was the commonest FGTB site with a frequency of 48 (46.60%), and fallopian tube, ovary and cervix showed a frequency of 31 (30.10%), 13 (12.62%) and 11 (10.68%) respectively (Table 1) .
| Diagnostic value of T-SPOT.TB in FGTB
T-SPOT.TB results from all the 103 patients with confirmed FGTB and 110 patients excluded from FGTB (control group) were analyzed in this study. 89 positive results were obtained in the FGTB group.
Whereas, only 27 positive T-SPOT.TB results were detected in the control group (Tables 2 and 3 95% CI, 36-93) (P < 0.05) ( Figure 1A ). The number of SFCs responding to ESAT-6 and CFP-10 antigens in FGTB group were both significantly different from those observed in control group (P < 0.01). in both PE and PB T-SPOT.TB test. Namely, there was no significant difference in specificity between PE and PB T-SPOT.TB (Table 2) . Furthermore, SFCs of PE T-SPOT.TB were significantly higher than that of PB T-SPOT.TB in the FGTB group (P = 0.01).
| Comparison of T-SPOT.TB results between PE and PB in FGTB detection
Whereas, there was no significant difference in SFCs between pelvic and peripheral blood T-SPOT.TB in controls (P = 0.77, Figure 1B ).
| Receiver operating characteristic (ROC) curve of T-SPOT.TB with PBMC and PEMC
Receiver operating characteristic (ROC) curve was used to evaluate the FGTB diagnostic value of T-SPOT.TB for both PBMC and PEMC samples. In this study, the area under the ROC curve of the overall of 213 PBMC was 85.56% (95% CI, 80.25% -90.87%, P < 0.01).
According to the ROC curve, the cut-off value of T-SPOT.TB for FGTB diagnose was 10 SFCs/2.5 × 10 5 PBMCs with a sensitivity of 82.5%, a specificity of 81.82% (Figure 2A ). On the other hand, the area under the ROC curve of the 18 PEMC samples was 93.2% (95%CI, 84.32% -100%). The cutoff value was 24 SFCs/2.5 × 10 5 PEMCs with a sensitivity of 94.44%, a specificity of 89.66% ( Figure 2B) 
| Results of conventional tests for FGTB diagnosis
Acid fast stain (AFB, Ziehl-Neelsen stain), M. tuberculosis culture and MTB-PCR were processed in all the FGTB patients and control patients with tissue biopsies (tissue sections and curettage) or fluid (pelvic and menstrual). Histopathological examination was performed for
TA B L E 2 The diagnostic parameters of T-SPOT.TB in female genital tuberculosis (FGTB)
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
Total patients (n = 213) PB (Table 3 ). In summary, T-SPOT.TB has significant higher sensitivity when compared with conventional tests in FGTB diagnosis, while the specificity of T-SPOT.TB is unsatisfactory.
| D ISCUSS I ON
So far, TB still imposes a heavy burden on public health in developing countries. 3 Although female genital tuberculosis accounts for only 0.5% TB cases, it leads to 10%-85% infertility and remains an indefinable diagnosis. 16 Reliable evidences especially with high specificity sensitivity and early diagnosis is critical for FGTB patients to avoid irreversible infertility caused by fibrosis. lower (8.38%) in this study let alone its lack of specificity. Raut reported that more than 45% of infertile patients with strong indirect evidence of FGTB had a negative microbiological results. 17 Histopathological examination is also commonly accepted in clinical extra pulmonary tuberculosis (EPTB) diagnosis. Still, the sensitivity here is unsatisfactory (58.23%) which is comparable to previously report. 7 Moreover, histopathological examination is invasive and needs patient compliance, which also limited its application in FGTB diagnosis. Theoretically, PCR has relatively high specificity and sensitivity. Whereas, the sensitivity of MTB-PCR is still significant lower when compared with T-SPOT.TB in this study (P < 0.01). This might be caused by the lack of M. tuberculosis containing tissue biopsy and proper diagnostic biomarkers. Bhanothu et al 15 reported that the use of multigene PCR with tissue biopsy and pelvic fluid, improved the sensitivity significantly in FGTB diagnosis. However, this technique is still clinically unavailable to date. In summary, a diagnostic tool with high specificity and sensitivity and easy to operate is under urgent need.
IGRAs have been used for the diagnosis of active TB and latent tuberculosis infection for a couple of year. [18] [19] [20] However, to date, only one report has analyzed the performance of IGRAs in FGTB diagnosis. 4 In our study, we not only analyzed the diagnostic efficacy of Previous study showed that the sensitivity of blood T-SPOT.TB was lower than pleural T-SPOT.TB, and false negative results were observed especially in patients with lymphopenia. Therefore, although further investigation need to be conducted, as to patients with pelvic effusion, pelvic T-SPOT.TB might be a more reasonable choice.
Our study demonstrated that T-SPOT.TB was very efficient in diagnosing FGTB. The sensitivity and specificity of T-SPOT.TB were comparable to its performance in other EPTBs. [22] [23] [24] Specificity in this study is relatively lower than that in studies conducted with pleural effusion in low and intermediate TB burden areas, in which the specificity was reported as 67.0%-90.5%. 4, 20, 22, 25 This might be due to the high LTBI rate in control group as in China, it was reported that the LTBI rate was 44.5% in a national wide TB survey in 2000. 26 The overall sensitivity is 86.41% in this study, although the result was lower than Liu's, there was no significant difference (χ 2 = 2.685, P = 0.10). According to Liu, the cutoff value of ROC curve was 10 SFCs/2.5 × 10 5 PBMCs, the same as ours. 4 However, for the PEMC samples, using 10 as cut-off value will lead to specific reduction.
According to our study, the cut-off was set to 24 SFCs/2. 27 As many patients with serve bacterium infection are immune compromised, patients with high bacterium burden might also result in low SFCs in T-SPOT.TB test. Also, the new cut-off value to be used for distinguishing active tuberculosis and LTBI might be different between pulmonary tuberculosis and EPTB. Therefore, further large-scale studies need to be performed to investigate whether SFCs number of T-SPOT.TB result is feasible to differentiate active TB and LTBI.
As is commonly implicated as the cause of infertility, FGTB usually causes irreversible damages to female genital system. Previous reports indicated that in vitro fertilization and embryo transfer (IVF-ET) procedure, the pregnancy rate of females with tuberculosis oviduct obstruction was significantly decreased when compared with those with nontuberculosis originated oviduct obstruction, even the patients had accepted complete course of anti-tuberculosis treatment. [28] [29] [30] Therefore, early diagnosis for FGTB using T-SPOT.TB test, which may facilitate timely treatment to avoid further damages to the genital system (one of the main causes of infertility) is of critical clinical significance.
In conclusion, T-SPOT.TB demonstrated high sensitivity and specificity in diagnosing FGTB in this study, which indicates that T-SPOT.TB is a useful adjunct for FGTB diagnosis. However, as there is no gold standard method for FGTB diagnosis and to compare T-SPOT.TB, one should use a combination of microbiological, histopathological and imaging examination for the final diagnosis. To our knowledge, this is the first report systematically valuing the performance of pelvic T-SPOT.TB in FGTB diagnosis. Further study, especially on larger population, will be needed to give more information about the characteristics of this diagnostic tool in FGTB diagnosis. 
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